Fluidx Medical Technology Press Releases - EIN Presswire

Published on August 6, 2026 - 11:07 GMT

Fluidx Medical Closes Financing to Advance Next-Generation Embolic Platform

Investment will support commercialization of GPX and ULTRA Embolic Devices and development of IMPASS neurovascular platform. SALT LAKE CITY, UT, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- Fluidx Medical Technology, Inc., a developer of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 24, 2026 - 14:04 GMT

Fluidx Completes Submission of Premarket Approval Application for the GPX® Embolic Device

Final module of PMA application submitted to FDA for easy to use, controllable embolic SALT LAKE CITY, UT, UNITED STATES, July 24, 2026 /⁨EINPresswire.com⁩/ -- Fluidx Medical Technology, Inc., a clinical stage medical device company advancing its …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 14, 2026 - 11:07 GMT

GPX® Embolic Device meets Primary Endpoints in an Investigational Device Exemption (IDE) Pivotal Trial

Trial Reports 99% Successful Occlusion of Flow with 40 Investigators Delivering the New Embolic Through 20 Different Catheters SALT LAKE CITY, UT, UNITED STATES, July 14, 2026 /⁨EINPresswire.com⁩/ -- Fluidx Medical Technology, Inc. announced the positive …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 2, 2026 - 12:30 GMT

Fluidx Announces Continued Clinical Success with ULTRA Embolic Gel

Novel gel embolic designed to give physicians greater control and consistency during embolization SALT LAKE CITY, UT, UNITED STATES, July 2, 2026 /⁨EINPresswire.com⁩/ -- Fluidx Medical Technology, Inc. today announced that its ULTRA Embolic Device …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on April 2, 2026 - 12:07 GMT

Fluidx Medical Announces First Patient Treated with Novel Embolic Gel

Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient. SALT LAKE CITY, UT, UNITED STATES, April 2, 2026 /⁨EINPresswire.com⁩/ -- Fluidx Medical Technology, Inc. announced today that the first patient has been …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 10, 2026 - 11:56 GMT

Fluidx IDE Trial Results Accepted for Late-Breaking Presentation at the SIR Annual Meeting

First podium presentation of IDE Clinical Trial Data of Novel Embolic Device to Treat Cancer SALT LAKE CITY, UT, UNITED STATES, February 10, 2026 /⁨EINPresswire.com⁩/ -- Fluidx Medical Technology, Inc. announced that results of the Investigational Device …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 7, 2026 - 12:07 GMT

IDE Pivotal Trial for Novel Liquid Embolic Device Completes Enrollment

Enrollment completed across 18 clinical sites with 40+ investigators in the US, Canada, and New Zealand SALT LAKE CITY, UT, UNITED STATES, January 7, 2026 /⁨EINPresswire.com⁩/ -- Fluidx Medical Technology, Inc. announced the completion of patient …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 27, 2024 - 12:10 GMT

Fluidx Medical Announces First Tumor Patient Treated in Prospective, Multinational Trial

Embolic device designed for improved preparation, delivery, and deep vessel filling for treating tumors and other interventional oncology uses. SALT LAKE CITY, UT, UNITED STATES, November 27, 2024 /⁨EINPresswire.com⁩/ -- Fluidx Medical Technology, Inc. …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 21, 2024 - 11:08 GMT

New Embolic Device for Tumor Treatment and Other Oncology Uses Given Nod by FDA to Start Pivotal Clinical Trial

Investigators look forward to evaluating the new device designed for simplicity, controlled delivery, and deep vessel filling SALT LAKE CITY, UTAH, UNITED STATES , May 21, 2024 /⁨EINPresswire.com⁩/ -- Fluidx Medical Technology, Inc. announced today that …

Distribution channels: Healthcare & Pharmaceuticals Industry ...